Since its FDA approval in 2008, transcranial magnetic stimulation (TMS) has evolved significantly, expanding its clinical applications and improving treatment strategies. Advancements in technology
The regulatory approval of transcranial magnetic stimulation (TMS) by the U.S. Food and Drug Administration (FDA) has been a critical milestone in the widespread adoption of TMS as a recognized medical treatment. The first FDA
Theta burst stimulation (TBS) is an advanced and efficient form of repetitive transcranial magnetic stimulation (rTMS) introduced in the early 2000s. Unlike traditional rTMS, which delivers evenly spaced pulses,
While single-pulse transcranial magnetic stimulation (TMS) was initially used in the 1980s for research and diagnostic purposes, it was limited in its ability to produce sustained effects
After Dr. Anthony Barker’s pioneering work in 1985, transcranial magnetic stimulation (TMS) underwent significant technological advancements that transformed it from an experimental tool into a widely used research and
In 1985, Dr. Anthony T. Barker and his research team at the Department of Medical Physics, Royal Hallamshire Hospital, University of Sheffield introduced transcranial magnetic stimulation (TMS)—a groundbreaking method
The concept of using electricity to influence muscle movement began in the 18th century, marking the initial steps toward modern brain stimulation techniques. Throughout history, scientists have
Depression is a serious mental health condition that affects millions of people across the globe. It can be debilitating, impacting nearly every aspect of life, including work, relationships, and daily routines. For many individuals, depression
Depression and mental health disorders affect millions of people across the United States, creating challenges that extend beyond mood. These conditions can impact relationships, career performance, physical health, and overall quality of life.
Mental health disorders are a growing concern worldwide. According to the World Health Organization, depression is one of the leading causes of disability globally, affecting over 300 million people. Anxiety disorders, obsessive-compulsive disorder (OCD), and post-traumatic stress
